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Yeast Phs1 is a 3-hydroxyacyl-CoA dehydratase involved in very long-chain fatty acid elongation. In
the present study, we biochemically characterized Phs1 mutants with Ala-substitution at each of
seven highly conserved amino-acid residues. All mutants exhibited reduced Phs1 activity. The
E60A, Q79A, and R141A mutants were sensitive to digitonin, indicative of their reduced structural
integrity. The fatty acid elongation cycle was greatly inhibited in the R83A, R141A, and G152A
mutant membranes. The enzyme kinetics study implicated the direct involvement of the Arg83
and Gly152 residues in the catalytic process. The E60A mutation was found to affect the substrate
speciﬁcity.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Very long-chain fatty acids (VLCFAs) are fatty acids (FAs) with a
chain-length greater than 20 carbon atoms (C20). Although much
less abundant than long-chain FAs (LCFAs; C11–C20), VLCFAs play
an important physiological function that cannot be substituted for
by LCFAs, such as retinal function, spermatogenesis, skin barrier
formation, and inﬂammation [1]. For example, VLCFA-deﬁcient
yeast as well as mice is known to be inviable [2,3]. VLCFAs are also
pathologically important, and several inherited disorders have
been linked to mutations in VLCFA-synthesizing and -degrading
genes [1].
VLCFAs are synthesized on the endoplasmic reticulum mem-
brane from LCFAs through the FA elongation cycle. In each cycle,
an acyl-CoA substrate is converted to an acyl-CoA product with
two additional carbons by four sequential reactions (condensation,
reduction, dehydration, and reduction) (Fig. S1A). The rate-limiting
step is the ﬁrst reaction, involving condensation of an acyl-CoA sub-strate with malonyl-CoA as a C2 donor [4]. 3-Hydroxyacyl-CoA
dehydratase is an enzyme that catalyzes the third reaction. In
2007, PHS1 was identiﬁed in yeast as the gene encoding 3-hydrox-
yacyl-CoA dehydratase [5]. Phs1 is highly conserved among eukary-
otes, and mammals have four Phs1 homologues (HACD1-4) [6].
In yeast, VLCFAs are predominantly used for the synthesis of
sphingolipids, which are one of the major lipid components of the
eukaryotic plasma membrane with many biological functions [7].
The sphingolipid backbone (ceramide) is composed of a long-chain
base and an amide-linked FA (C26 for yeast; mainly C16 and C24 for
mammals) [1,7]. Therefore, any mutation in a gene involved in
VLCFA production interferes with sphingolipid synthesis. For exam-
ple, when the yeast PHS1 mRNA was not transcribed using a con-
trollable tetracycline (doxycyclin)-dependent promoter (Tet-PHS1
cells), the complex sphingolipid level was decreased, whereas the
ceramide and long-chain base levels were increased [8].
Phs1 is an integral membrane protein with six membrane-span-
ning domains [8]. However, Phs1 and its family members have no
known domains or sequence motifs and exhibit no sequence sim-
ilarity to other protein families. To identify the amino-acid resi-
dues important for Phs1 function, we previously created Phs1
mutants by substituting each of 22 amino-acid residues, which
are conserved among 31 Phs1 family members, with Ala, and intro-
duced each mutant into Tet-PHS1 cells [8]. The cells producing one
T. Yazawa et al. / FEBS Letters 587 (2013) 804–809 805of nine mutant proteins (E60A, Q79A, R83A, E116A, R119A, R141A,
Y149A, G152A, or E156A) accumulated the long-chain base phyto-
sphingosine, indicative of a defect in Phs1 activity [8]. In addition,
two of these nine mutants (Y149A and E156A) neither comple-
mented the growth defect of Tet-PHS1 cells in the presence of
doxycyclin nor exhibited the enzyme activity. Thus, both Tyr149
and Glu156 residues were considered to be a part of the active site.
Although the rest of the seven amino-acid residues were expected
to be important for Phs1 function, their precise role still remains
unclear. In the present study, we have performed several biochem-
ical analyses on the seven remaining mutants and identiﬁed the
amino-acid residues important for the catalysis, structural mainte-
nance, and substrate speciﬁcity of Phs1.
2. Materials and methods
2.1. Yeast strains, plasmids, and media
The Saccharomyces cerevisiae strain DEY195 (MATahis3D1
leu2D0 met15D0 ura3D0 pep4D::MET25) is a derivative of BY4741
[9]. The plasmid encoding the wild-type PHS1-3xFLAG (pSH14) or
the mutant PHS1-3xFLAG (pSH18, E60A; pSH19, Q79A; pSH20,
R83A; pSH22, E116A; pSH23, R119A; pSH25, R141A; and pSH30,
G152A) under the control of MET25 promoter was introduced into
the DEY195 cells. The phs1D::LEU2 mutation was introduced into
each of the resultant cells, generating YTY19 (wild type), YTY20
(E60A), YTY21 (Q79A), YTY22 (R83A), YTY23 (E116A), YTY24
(R119A), YTY25 (R141A), and YTY26 (G152A), respectively. All
the plasmids were constructed as described previously [8]. Cells
were grown in synthetic complete (SC) medium (0.67% yeast nitro-
gen base, 2% D-glucose, and nutritional supplements) but lacking
histidine and methionine (SC-His–Met) at 30 C.
2.2. In vivo 3-hydroxyacyl-CoA dehydratase assay
Yeast spheroplasts prepared as described previously [10] were
suspended in buffer A (50 mM HEPES–KOH (pH 6.8), 150 mM
KOAc, 2 mMMg(OAc)2, 1 mM CaCl2, 200 mM sorbitol, 1 mM dithi-
othreitol, 1 mM phenylmethylsulfonyl ﬂuoride, and a 1X Com-
plete™ protease inhibitor mixture (EDTA-free; Roche Diagnostics,
Indianapolis, IN, USA) and lysed by sonication. Unlysed cells were
removed by centrifugation at 2000g for 3 min. The supernatant
was centrifuged at 100000g for 30 min at 4 C, and the resulting
pellet (total membrane fractions) was suspended in buffer A. The
assay was performed using 3-hydroxy[1-14C]palmitoyl-CoA
(55 mCi/mmol; American Radiolabeled Chemicals, St. Louis, MO,
USA) as described previously [8].
2.3. In vitro FA elongase assay
The assay was performed using acyl-CoAs (C16–C24) and
[2-14C]malonyl-CoA (55 mCi/mmol; American Radiolabeled Chem-
icals) as described previously [11].
2.4. Immunoblotting
Immunoblotting was performed as described previously [8],
using the anti-FLAG antibody M2 (1 lg/ml; Stratagene, Agilent
Technologies, La Jolla, CA, USA) and anti-Pma1 (yN-20) antibody
(0.4 lg/ml; Santa Cruz Biotechnology, Santa Cruz, CA, USA) as the
primary antibodies, and HRP-conjugated anti-mouse and anti-goat
IgG F(ab0)2 fragments (each at 1:7500 dilution; GE Healthcare Bio-
Sciences, Piscataway, NJ, USA) as the secondary antibodies. Label-
ing was detected using Pierce Western Blotting Substrate (Thermo
Fisher Scientiﬁc, Waltham, MA, USA).3. Results
3.1. The Glu60, Gln79, Arg83, Glu116, Arg119, Arg141, and Gly152
residues are important for the enzyme activity of Phs1
We individually substituted the seven conserved amino-acid
residues of Phs1 (Glu60, Gln79, Arg83, Glu116, Arg119, Arg141,
and Gly152) with Ala and constructed phs1D strains expressing
each of these Ala-substituted mutants (E60A, Q79A, R83A, E116A,
R119A, R141A, and G152A) as an N-terminally 3xFLAG-tagged pro-
tein. Using total membrane fractions prepared from these yeast
cells and 3-hydroxy[1-14C]palmitoyl-CoA as a substrate, we exam-
ined their 3-hydroxyacyl-CoA dehydratase activity (Fig. 1A). All the
mutants exhibited reduced activities compared to the wild-type
Phs1, with R83A mutant having the lowest activity. Their intracel-
lular level was similar or slightly higher compared to that of the
wild-type Phs1, except for the E60A and R119A mutants whose
levels were lower (Fig. 1B).
We then repeated the assay in the presence of the non-ionic
detergent digitonin (Fig. 1C). The activity of the R83A, E116A,
R119A, and G152A mutants, as well as the wild-type Phs1, was less
affected by treatment with digitonin; however, the activity of the
E60A, Q79A, and R141A mutants was signiﬁcantly reduced
(Fig. 1C). These results suggest that the mutation in the Glu60,
Gln79, or Arg141 residue affect the structural integrity of Phs1.
3.2. The R83A, R141A, and G152A mutations cause a decrease in acyl-
CoA production during the FA elongation cycle
FA elongation takes place by cycling through a 4-step reaction,
and each step is catalyzed by a speciﬁc enzyme (Fig. S1A). To
examine the effect of the PHS1 mutation on the overall FA elonga-
tion cycle, we performed an in vitro FA elongation assay using total
membrane fractions, palmitoyl-CoA (C16-CoA) (the substrate of
the ﬁrst step) and [14C]malonyl-CoA. The reaction products were
analyzed by normal-phase TLC after hydrolysis to the correspond-
ing FA derivatives (Fig. 2A and B). Since the ﬁrst condensation step
is the rate-limiting step of the FA elongation cycle, acyl-CoA (the
product; FA in the ﬁgure) was detected as the only product of
the wild-type membrane. On the other hand, all the mutant mem-
branes accumulated 3-hydroxyacyl-CoA (the substrate of Phs1) (3-
hydroxy-FA in the ﬁgure) in addition to the acyl-CoA product,
reﬂecting their reduced Phs1 activity. Most of the mutant mem-
branes tend to produce a reduced level of acyl-CoA, and a signiﬁ-
cant reduction was observed for the R83A, R141A, and G152A
mutant membranes.
3.3. The substrate speciﬁcity of Phs1 is affected by the E60A mutation
To elucidate the effect of each mutation on the progression of
the FA elongation cycle, we determined the chain-length proﬁle
of FA and 3-hydroxy-FA by reversed-phase TLC after conversion
to the corresponding methyl esters (FA methyl ester (FAME) and
3-hydroxy-FAME, respectively) (Fig. 3A and B). The wild-type
membrane elongated C16-CoA up to C26-CoA (C26 FAME in the
ﬁgure), indicating that C16-CoA underwent ﬁve rounds of the elon-
gation cycle (Fig. S1B). The upper two spots having the same Rf val-
ues (the ratio of distances migrated by the sample and the solvent
front) with 3-hydroxy-C24-FAME and 3-hydroxy-C26-FAME
should be associated only with C18-FAME and C20-FAME, respec-
tively (Fig. 3A), since the wild-type membrane accumulated little
3-hydroxyacyl-CoA (Fig. 2A). The E60A, Q79A, E116A, and R119A
mutant membranes also produced C18- to C26-CoAs, while the
C26-CoA level was much lower than that produced by the wild-
type membrane. As expected, these mutant membranes accumu-
Fig. 1. The Glu60, Gln79, Arg83, Glu116, Arg119, Arg141, and Gly152 residues are
important for Phs1 activity. (A–C) Total membrane fractions were prepared from
YTY19 (wild type; WT), YTY20 (E60A), YTY21 (Q79A), YTY22 (R83A), YTY23
(E116A), YTY24 (R119A), YTY25 (R141A), and YTY26 (G152A) cells. (A) Total
membrane fractions (4 lg) were incubated with 3.6 lM 3-hydroxy[1-14C]palmi-
toyl-CoA (0.01 lCi) for 15 min at 37 C. After termination of the reactions, lipids
were saponiﬁed, acidiﬁed, extracted, and separated by normal-phase TLC. The
radioactivity associated with the reaction product 2,3-trans hexadecenoic acid was
quantiﬁed using a bioimaging analyzer BAS-2500 (Fuji Film, Tokyo, Japan). Values
represent the mean ± S.D. of three independent experiments. Statistically signiﬁ-
cant differences from the wild type are indicated (⁄P < 0.05, ⁄⁄P < 0.01; t-test). (B)
Total membrane fractions (3 lg) were separated by SDS–PAGE and detected by
immunoblotting with anti-FLAG antibody or, to normalize protein loading, with
anti-Pma1 (a plasma membrane protein) antibody. The values below the gel image
are the relative amount of each Phs1-3xFLAG, after normalization with Pma1, to the
wild-type protein. (C) Total membrane fractions (4 lg) were subjected to a 3-
hydroxyacyl-CoA dehydratase assay as in (A) with or without 1% digitonin. Values
represent the mean ± S.D. of three independent experiments. Statistically signiﬁ-
cant differences are indicated (⁄P < 0.05; t-test).
Fig. 2. The R83A, R141A, G152A mutant membranes exhibit a decreased acyl-CoA
production in the FA elongation cycle. (A and B) Total membrane fractions (20 lg)
prepared from YTY19 (wild type; WT), YTY20 (E60A), YTY21 (Q79A), YTY22 (R83A),
YTY23 (E116A), YTY24 (R119A), YTY25 (R141A), and YTY26 (G152A) cells were
incubated with 50 lM palmitoyl-CoA and 27.3 lM [2-14C]malonyl-CoA (0.075 lCi)
for 30 min at 37 C. Lipids were saponiﬁed, acidiﬁed, extracted, and separated by
normal-phase TLC. Using a bioimaging analyzer BAS-2500, the radioactivity was
detected (A) and quantiﬁed (B). Values represent the mean ± S.D. of three
independent experiments. Statistically signiﬁcant differences from the wild type
are indicated (⁄P < 0.05, ⁄⁄P < 0.01; t-test).
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The R83A, R141A, and G152A mutations had a more signiﬁcant
effect on the FA elongation cycle. Their acyl-CoA product and 3-
hydroxyacyl-CoA intermediate were predominantly C18-CoA and
3-hydroxy-C18-CoA, respectively (Fig. 3A and B). Most of the FA
elongation cycle in these mutant membranes seem to have
stopped during and after the ﬁrst round (Fig. S1B).It is noteworthy that the E60A mutant membrane accumulated
a rather high level of 3-hydroxy-C20- and 3-hydroxy-C22-CoA
with reference to the level of 3-hydroxy-C18-CoA. Both levels were
highest among the mutant membranes. It seems that the E60A mu-
tant exhibits higher activity toward 3-hydroxy-C18-CoA than 3-
hydroxy-C20- and 3-hydroxy-C22-CoA, whereas the wild-type
Phs1 and other mutants maintain a similar activity toward 3-
hydroxyacyl-CoA regardless of their chain-length. To test this pos-
sibility, we performed the FA elongation assay using acyl-CoA sub-
strates with different chain-length (C16- to C24-CoAs) (Fig. S2A
and B). The primary product of the wild-type membrane was
acyl-CoA, irrespective of the substrate used. The 3-hydroxyacyl-
CoA intermediate was detected less than 4% of the total product
(acyl-CoA plus 3-hydroxyacyl-CoA). In contrast, in the E60A mu-
tant membrane, the percentage of the acyl-CoA product decreased
from 48% to 24% and to <10% as the substrate chain-length in-
Fig. 3. Substrate speciﬁcity is affected in the E60A mutant. (A and B) Total
membrane fractions (20 lg) prepared from YTY19 (wild type; WT), YTY20 (E60A),
YTY21 (Q79A), YTY22 (R83A), YTY23 (E116A), YTY24 (R119A), YTY25 (R141A), and
YTY26 (G152A) cells were incubated with 20 lM palmitoyl-CoA, 73 lM malonyl-
CoA, and 27.3 lM [2-14C]malonyl-CoA (0.075 lCi) for 30 min at 37 C. Lipids were
saponiﬁed, acidiﬁed, and extracted. After methyl esteriﬁcation, the esters were
separated by reversed-phase TLC. Using a bioimaging analyzer BAS-2500, the
radioactivity was detected (A) and quantiﬁed (B). Values represent the mean ± S.D.
of three independent experiments. For the wild type, the radioactivity of the two
spots corresponding to C18-FAME/3-hydroxy-C24 FAME and C20-FAME/3-hydroxy-
C26-FAME was considered to be derived mainly from C18-FAME and C20-FAME,
respectively, since little accumulation of 3-hydroxy-CoA (i.e., 3-hydroxy-FAME)
(<10%) was detected in the wild-type membrane (see Fig. 2A).
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jected the R119A and R141A mutant membranes to the assay
and found that the percentage of the acyl-CoA product was much
less variable than the E60A mutant membrane. Thus, the lower
activity toward 3-hydroxyacyl-CoA with longer chain-length
seems characteristic of the E60A mutant.
3.4. Both R83A and G152A mutants display normal Km but reduced
Vmax values
Three mutants (R83A, R141A, and G152A) exhibited severe FA
elongation defects (Figs. 2 and 3). The Arg83 and Gly152 residues
are located in the interior of the ER membrane, where the putativeactive site residues Tyr149 and Glu156 are present [8] (Fig. S3).
Therefore, it is possible that the Arg83 and Gly152 residues are di-
rectly involved in the catalytic process, although the possible
involvement of other residues cannot be excluded. On the other
hand, the Arg141 residue is located outside the ER membrane (in
the cytosolic loop), and the R141A mutant was sensitive to digito-
nin (Fig. 1C). Thus, the decreased activity of the R141A mutant is
likely derived from a defect in structural integrity. To examine
these possibilities, we determined the Km and Vmax values of the
R83A, G152A, and R141A mutants and compared them with those
of the wild-type Phs1 (Fig. 4A–C). The Km values of the R83A and
G152A mutants were 2.70 and 2.50 lM, respectively, which were
slightly lower than that of the wild-type Phs1 (5.5 lM), suggesting
that the substrate–enzyme afﬁnity was not impaired by these
mutations. The Vmax values of the R83A and G152A mutants
(0.08 and 0.11 pmol/ng/min, respectively) were lower by 1000-
fold compared to that of the wild-type Phs1 (84.0 pmol/ng/min).
These results suggest that the catalytic process, but not the sub-
strate recognition, was affected by the R83A and G152A mutations.
The R141A mutant, however, exhibited a higher Km and lower Vmax
than the wild type Phs1 (Km, 15.4 lM; Vmax, 0.54 pmol/ng/min)
(Fig. 4C), which could imply that the structural defect had an ad-
verse effect on both substrate recognition and catalytic process.
4. Discussion
Phs1 and its homologs belong to a novel 3-hydroxyacyl-CoA
dehydratase family with no sequence similarity to other protein
families. The three-dimensional structure is not currently available
for any of the Phs1 family members. We previously identiﬁed nine
amino-acid residues important for Phs1 function by expressing
Phs1 mutants, in which each of the 22 conserved residues was re-
placed by Ala, in Tet-PHS1 cells [8]. Among these residues, the
Tyr149 and Glu156 residues were found to be essential and consid-
ered as the putative active-site residues. However, the speciﬁc role
of seven other residues needs to be investigated. Accordingly, we
have carried out several biochemical analyses on the correspond-
ing Ala-substituted Phs1 mutants prepared previously.
The 3-hydroxyacyl-CoA dehydratase assay showed that the ex-
pected lower activity for all the mutants (Fig. 1A). Since the activity
of the E60A, Q79A, and R141A mutants was reduced by treatment
with the non-ionic detergent digitonin (Fig. 1C), the Glu60, Gln79,
and Arg141 residues seem important for the structural mainte-
nance of Phs1. The immunoblot analysis revealed that the E60A
protein level was the lowest (Fig. 1B). It is possible that the E60A
mutant is destabilized in the ER membrane due to its reduced
structural integrity.
From the results of the FA elongation assay (Fig. 3), we have
classiﬁed the mutants into two classes (Class I: E60A, Q79A,
E116A, and R119A; Class II: R83A, R141A, and G152A) (Fig. S1B).
The Class I mutant membranes exhibited a moderate FA elongation
defect and elongated C16-CoA to C26-CoA (the product of the 5th
elongation cycle), but in a lesser amount than the wild-type mem-
brane. On the other hand, the Class II mutant membranes displayed
a severe FA elongation defect yielding primarily C18-CoA (the
product of the ﬁrst elongation cycle) and 3-hydroxy-C18-CoA
(the ﬁrst round substrate for Phs1) in 11–22% and 51–78% of the
total products, respectively. Thus, most of the elongation cycle in
the Class II mutant membranes ended during and after the ﬁrst
round. It appears that the Ala-substituted residues in the Class II
mutants (Arg83, Arg141, and Gly152) are particularly important
for the normal function of Phs1.
We previously predicted the membrane topology of Phs1 to
have six membrane-spanning domains with both N- and C-termini
facing the cytosol, and hypothesized the catalytic mechanism for
Fig. 4. The R83A and G152A mutations result in a reduced Vmax value. (A) Total
membrane fractions (0.16 lg) prepared from YTY19 (wild type; WT) were
incubated with 2, 4, 9, 12, 16, 24, and 36 lM 3-hydroxy[1-14C]palmitoyl-CoA
(0.1 lCi/ml) for 1 min at 37 C. After termination of the reaction, lipids were
saponiﬁed, acidiﬁed, extracted, and separated by normal-phase TLC. The radioac-
tivity associated with the reaction product 2,3-trans hexadecenoic acid was
quantiﬁed using a bioimaging analyzer BAS-2500. The Phs1-3xFLAG level in the
membrane fractions used was determined relative to the level of the 3xFLAG-
maltose binding protein standard, and used for the calculation of the speciﬁc
activity. The obtained values were expressed in a Lineweaver–Burk plot with a
linear regression line. R is a correlation coefﬁcient. (B) Total membrane proteins
(4 lg) prepared from YTY22 (R83A) and YTY26 (G152A) cells were incubated with
2, 4, 8, and 16 lM 3-hydroxy[14C]palmitoyl-CoA for 15 min at 37 C. The Km and
Vmax values were determined as in (A). (C) Total membrane proteins (4 lg) prepared
from YTY25 (R141A) cells were incubated with 0.5, 4, 8, and 16 lM 3-
hydroxy[14C]palmitoyl-CoA for 15 min at 37 C. The Km and Vmax values were
determined as in (A).
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3-hydroxyacyl-acyl carrier protein dehydratase FabA [12,13]. ThePhs1-catalyzed a, b-elimination of 3-hydroxyacyl-CoA may pro-
ceed through either a concerted or a stepwise manner involving
enolization followed by dehydration. Accordingly, we have reﬁned
our originally proposed mechanism to illustrate these two possibil-
ities (Fig. S4). Thus, during the catalytic process, the Tyr149 residue
functions as a base in its phenoxide form abstracting the a-hydro-
gen of the 3-hydroxyacyl-CoA substrate, and the Glu156 residue
likely acts as an acid to donate a proton to the b-hydroxyl group
of the substrate for its elimination as water. In the concerted mech-
anism, these two processes occur simultaneously in a concerted
fashion, while the stepwise mechanism involves the initial forma-
tion of an enolate intermediate followed by elimination of the b-
hydroxyl group. The Arg83 and Gly152 residues are probably
important for the generation/stabilization of the Tyr149 phenoxide
(by salt bridge formation) and the stabilization of the eliminated
water as well as its removal from the active site (through hydrogen
bond interaction). In addition, in the stepwise mechanism, the
Gly152 residue could stabilize the enolate intermediate by hydro-
gen bonding to the enolate oxygen. Based on the report that yeast
ER membrane proteins typically traverse the membrane via the
hydrophobic stretch of 15 amino-acid residues [14], as well as
the hydropathy plot of Phs1 [15], we have slightly modiﬁed our
original membrane topology model for Phs1 by revising the length
of the transmembrane domain from 18 to 15 residues (Fig. S3). In
the revised model, the 2 catalytic residues (Tyr149 and Glu156), as
well as the two key residues (Arg83 and Gly152), still remain in the
interior of the ER membrane. The proposed direct involvement of
the Arg83 and Gly152 residues in the catalytic process is consistent
with the enzyme kinetics data revealing that both R83A and G152A
mutations resulted in the Phs1 mutants with the greatly reduced
Vmax values without affecting their Km values (Fig. 4B). On the other
hand, the Arg141 residue resides in the cytoplasmic domain of
Phs1 (Fig. S3), and hence its direct involvement in the catalytic pro-
cess is unlikely. Rather, the Arg141 residue may be required for
structural maintenance of the active site, since the activity of the
R141A mutant was decreased upon digitonin treatment (Fig. 1C).
Indeed, the R141A mutation had a negative effect on both Km
and Vmax values (Fig. 4C).
The E60A mutant seemed to have the highest substrate speciﬁc-
ity to 3-hydroxy-C18-CoA over the other longer-chain 3-hydroxya-
cyl-CoAs (Fig. 3 and Fig. S2). For example, the ratio of 3-hydroxy-
C20-CoA to 3-hydroxy-C18-CoA was 87% in E60A mutant
membrane, whereas the ratio was much lower in other Class I
and Class II mutant membranes (47–52% and 6–32%, respectively)
(Fig. 3B). This ﬁnding is interesting, considering that the C16- and
C18-FAs are the major FA components of glycerophospholipids, the
most abundant lipids in the ER. During the FA elongation cycle, an
acyl-CoA substrate is believed to be located in the cytoplasmic leaf-
let of the ER lipid bilayer with its CoA moiety in the cytosol.
Through repetitive addition of C2 units, the methyl end of the acyl
chain traverses from the cytosolic to the luminal leaﬂet. The
Glu60 residue is located near the interface between the two
leaﬂets of the ER lipid bilayer (Fig. S3). Accordingly, we speculate
that the E60A mutation causes a structural change that interferes
with the accommodation of longer FA chains, especially longer
than C20.
In the present study, we have obtained biochemical information
revealing the amino-acid residues important for the catalysis,
structural maintenance, and substrate speciﬁcity of Phs1. Since
being conserved among the Phs1 family, these identiﬁed residues
may play a similar role in the eukaryotic HACD proteins. The muta-
tion in dog HACD1 is found to cause canine centronuclear myopa-
thy [16]. Future studies may identify additional HACD-related
disorders. Therefore, our ﬁndings will be useful for understanding
the relationships among mutations, enzyme activities, and
pathologies.
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